Intravenous phenobarbital therapy in barbiturate and other hypnosedative withdrawal reactions: A kinetic approach
The DOI matches its Crossref record.
Abstract
Phenobarbital (0.03 to 0.04 mg/kg/min) was infused intravenously in 7 patients with clinical hypnosedative withdrawal reactions until patients slept but were arousable. The infusion time to reach this clinical end point was 7.8 ± 1.1 hr (mean ± SEM), the total dose was 992 ± 144 mg, and the peak serum phenobarbital concentration was 26.1 ±5.1 µg/ml. A user of minimal hypnosedatives required 54% less phenobarbital and 65% lower concentration than any of the abusers to reach an equivalent state of intoxication. The mean serum half‐life (t½) was 57.5 ± 4.9 hr for hypnosedative abusers and 86 ± 3 hr for 8 normal volunteers (p < 0.001). Only the patient with the shortest t½ (36.4 hr) required oral phenobarbital supplements to prevent withdrawal symptoms. Dosage supplements required can be calculated from the postinfusion rate of fall of serum phenobarbital. Slow infusion of large amounts of phenobarbital provides a safe, efficacious single‐dose treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mo, Y., Thomas, M. C., & Karras, G. E. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.11.022 · Cited by 47
Enduring neurological sequelae of benzodiazepine use: an Internet survey
Huff, C., Finlayson, A. J. R., Foster, D. E., & Martin, P. R. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221145561 · Cited by 18
Self-citationLong-term neurological consequences following benzodiazepine exposure: A scoping review
Shade, K. N., Ritvo, A. D., Silvernail, B., Finlayson, A. J. R., Bressi, J. E., Foster, D. E., Martin, I. J., Piper, C., & Martin, P. R. (2025) · PLOS One · doi:10.1371/journal.pone.0330277 · Cited by 7
“There are established treatment protocols for benzodiazepine acute withdrawal syndrome [10,72,73].”
Self-citation
Metadata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intravenous phenobarbital therapy in barbiturate and other hypnosedative withdrawal reactions: A kinetic approach. https://app.cochat.ai/papers/10.1002/cpt1979262256
- The paper
- Martin, P. R., Kapur, B. M., Whiteside, E. A., & Sellers, E. M. (1979). Intravenous phenobarbital therapy in barbiturate and other hypnosedative withdrawal reactions: A kinetic approach. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt1979262256
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.